Settlement Reached with Takeda for $2.4 Billion for Actos Bladder Cancer LitigationApril 29th, 2015
We are no longer accepting new cases.
Weitz & Luxenberg’s Paul Pennock was one of two court-appointed lead counsel on the Plaintiffs Steering Committee for the multidistrict litigation against drug manufacturer Takeda. The litigation was for the diabetes drug Actos, which may cause bladder cancer. Read more in The Wall Street Journal article, Takeda Pharmaceutical to Pay up to $2.4 Billion to Settle U.S. Lawsuits.